|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
3.86/6.97
|
企业价值
128.88B
|
资产负债 |
每股账面净值
8.13
|
现金流量 |
现金流量率
0.15
|
损益表 |
收益
45.01B
|
每股收益
22.17
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/11 19:53 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group. |